Fierce Pharma
OCTOBER 2, 2024
Gilead Sciences is wasting no time in promoting worldwide access to its twice-yearly pre-exposure prophylaxis (PrEP) HIV candidate lenacapavir. | The company will allow six generic manufacturers to make and sell its long-acting PrEP drug, lenacapivir, in 120 resource-limited countries.
MedCity News
OCTOBER 2, 2024
Alpine Physician Partners — which operates primary care organizations in several states — is implementing Ambience Healthcare’s documentation and coding tool after a successful pilot. Before adopting Ambience’s tool, Alpine clinicians spent 4.7 hours on charting per day, but now that time has dropped down to 1.2 hours per day. The post How A Physician Group Is Using AI to Save Clinicians 3+ Hours Per Day on Documentation appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
OCTOBER 2, 2024
Aspen Neuroscience, underway with Parkinson's cell therapy trial, bolsters manufacturing with new San Diego facility fkansteiner Wed, 10/02/2024 - 07:31
MedCity News
OCTOBER 2, 2024
SCAN Health Plan and Astrana Health recently launched SCAN Allied, a Medicare Advantage plan designed for the Asian older adult population. It includes access to a network of culturally competent providers, specialists and pharmacies from Astrana Health. The post SCAN, Astrana Launch MA Plan Tailored to Asian Older Adults appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
OCTOBER 2, 2024
While they were both approved several years back to treat the same two types of prostate cancer, Astellas and Pfizer’s Xtandi has held a larger slice of the market than Johnson & Johnson’s riva | A real-world, head-to-head study of two androgen receptor pathway inhibiting (ARPI) prostate cancer drugs indicates that Johnson & Johnson’s Erleada provides an edge in overall survival versus Astellas and Pfizer’s Xtandi.
MedCity News
OCTOBER 2, 2024
Investing in nurses — by reimbursing them based on the value of their work — can improve job satisfaction thus reducing the churn rate and attracting more to the profession. The post Who Wins When Nurses Are Reimbursed for Care Delivery? appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
OCTOBER 2, 2024
A federal judge in New York has ruled that Amgen must answer to claims of misleading investors about billions owed to US tax authorities, allowing a securities-fraud class action to proceed against the pharmaceutical giant.
Fierce Pharma
OCTOBER 2, 2024
Sitting down with Emily Keith, SVP at AdTheorent Health, at Digital Pharma East 2024, we explored the cutting-edge int | Sitting down with Emily Keith, SVP at AdTheorent Health, at Digital Pharma East 2024, we explored the cutting-edge intersection of healthcare, advertising and privacy.
MedCity News
OCTOBER 2, 2024
A more measured approach to noncompete clauses can be fair to physicians and provider organizations, and also serve patients better. Here are four elements for a policy on noncompetes that will work for healthcare. The post Forging a Noncompete Policy That Works for Healthcare appeared first on MedCity News.
Fierce Pharma
OCTOBER 2, 2024
Founded in 2005, Phreesia provides cutting-edge technology that helps healthcare organizations engage patients more effe | Founded in 2005, Phreesia provides cutting-edge technology that helps healthcare organizations engage patients more effectively, empowering them to take an active role in their care. By enhancing patients’ understanding, skills, and confidence, the company is revolutionizing the way healthcare content is delivered.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
MedCity News
OCTOBER 2, 2024
Lilly Medicine Foundry will research new ways to manufacture medicines. Eli Lilly says in addition to supporting the manufacturing of drugs for clinical trials, manufacturing innovations from the site will be transferred to the company’s other facilities for use in full-scale drug production. The post Eli Lilly Plans $4.5B Medicine Foundry to Foster Innovations in Drug Manufacturing appeared first on MedCity News.
Fierce Pharma
OCTOBER 2, 2024
Courtney Walker, Chief Growth Officer at MMC and RXMosaic, discusses the evolving role of communicators and the future of the healthcare industry. | While AI will reshape communications and existing roles for the healthcare industry, human connection remains crucial for building trust with patients.
Pharmaceutical Technology
OCTOBER 2, 2024
Exscientia detailed how its robotics lab in Oxfordshire, UK is increasing productivity and efficiency in developing new molecules at ELRIG 2024.
pharmaphorum
OCTOBER 2, 2024
In a bold move to tackle soaring drug costs, Blue Shield of California is pioneering a strategy that bypasses traditional pharmacy benefit managers to slash the cost of Humira by 90%
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Pharmaceutical Technology
OCTOBER 2, 2024
The funds will support the development of LoQus23’s lead candidate, its MutSβ inhibitor, as it enters clinical development.
Clarivate
OCTOBER 2, 2024
Funders, governments and institutions across the globe are increasingly expected to demonstrate the societal impact of research. They need to answer questions such as: has investment in research and experimental development (R&D) yielded tangible benefits to individuals, communities, organizations and economies across diverse areas such as health, climate change and technological advancement?
pharmaphorum
OCTOBER 2, 2024
In the VP debate, Tim Walz and JD Vance were forceful, unexpectedly convivial, and fast and loose with the facts, particularly on healthcare.
PharmaTimes
OCTOBER 2, 2024
ISM001-055 shows promise in improving lung function among patients
European Pharmaceutical Review
OCTOBER 2, 2024
Genentech (a member of the Roche Group) has agreed to acquire next-generation CDK inhibitors for breast cancer from Regor Pharmaceuticals for $850 million. Regor is eligible for further payments dependent on whether certain development, regulatory and commercial milestones are met. Genentech is responsible for clinical development, manufacturing and commercialisation globally. “Genentech is well-positioned to bring these novel therapeutics to their full potential,” commented Xiayang
pharmaphorum
OCTOBER 2, 2024
FDA issues summary of grants, promotes rare disease research Nicole.
PharmaTimes
OCTOBER 2, 2024
Preclinical data on NeuroRestore therapy to be showcased at CTAD in Madrid
Clarivate
OCTOBER 2, 2024
Welcome to the latest installment of Top 100 Global Innovators from Clarivate report series, where we take an in-depth look at the top players and global trends driving innovation across several key industries. In this edition, we focus on the automotive segment — a cornerstone of modern industry currently navigating a storm of innovation convergence driven by the rise of electric vehicles (EVs), autonomous driving technologies and connected vehicle systems powered by the Internet of Things (IoT
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
PharmaVoice
OCTOBER 2, 2024
The official launch comes five months after a filing indicated major investors such as Atlas Venture and Bain Capital were backing the biotech, then named “Hercules CM NewCo.
Pharmaceutical Commerce
OCTOBER 2, 2024
In this paper, UBC's Senior Clinical Program Manager, Amanda Scholz, MHA, BSN, RN, discusses the important role that clinical adherence programs play in empowering patients and bolster persistence to prescribed life-changing medications throughout their journey.
PharmExec
OCTOBER 2, 2024
Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development.
Pharmaceutical Commerce
OCTOBER 2, 2024
In this podcast, we speak with Amanda Scholz, UBC Senior Clinical Program Manager, MHA, BSN, RN as we discuss the important role that clinical adherence programs play in empowering patients and bolster persistence to prescribed life-changing medications throughout their journey.
Contrarian Sales Techniques
OCTOBER 2, 2024
Selling cars used to be all about firm handshakes, flashy brochures, and convincing people to come down to the dealership for a test drive. But let’s face it.times have changed. In today’s fast-paced, digital world, car sales are no longer just about face-to-face interactions. Now, customers research online, watch videos, compare reviews, and often know exactly what they want before even stepping foot on the lot.
PharmExec
OCTOBER 2, 2024
Marketed as a biosimilar to Stelara, approval of Otulfi was based on clinical data demonstrating comparable efficacy in treating inflammatory conditions such as Crohn disease, ulcerative colitis, moderate to severe plaque psoriasis, and active psoriatic arthritis.
Pharmaceutical Commerce
OCTOBER 2, 2024
When it comes to navigating the complex clinical and commercial landscape for specialty drugs—including hurdles in access to these critical but costly therapies—today’s specialty pharmacies are bringing more skills and services to the table.
PharmaTech
OCTOBER 2, 2024
This premiere episode of Sexy Science in Pharmaceuticals features Professor Jonathan Pokorski, UC San Diego Jacobs School of Engineering, and Dr. James DiNunzio, Senior Principal Scientist at Merck & Co., Inc. in Rahway, NJ, discussing the benefits of hot-melt extrusion.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
324 
Let's personalize your content